bausch was up. thhe analyst says drug maker is exhibiting earnings stability as well as the potential for long-term growth. price rget, $27. bausch is the company formerly known as valiant pharmaceuticals. shares rose 9.5% to $23.23. cvs was updated toqual weight at stevens. stronger pricing, price target now $58 and that stocke r 4% to $45.66. >>> still ahead, some strategist say cas is king in this uncertainty market, but what does that mean, at should you do with your mon? >> one of the best performing asset classes last year was of all things, sh and more than a few money managers have increased their cash levels because of all of the stock market volatility. joining us tonight to talk short term cash strategies, good to see you happy newyear. >> happy new year. >> i know you're on a little higher cash level than your own portfolio these days. united advocate a long-term cash strategy. if you're holding cash right up, other than just sitting and earning nothing, what do you do with that cash the